Opioid abuse therapy may be more effective if patients are screened for hepatitis C as part of the program, a new Canadian study says.
The research found a sharp drop in opioid abuse among patients after they were told they tested positive for the hepatitis C virus (HCV). Hepatitis C causes liver disease that can lead to cirrhosis (scarring of the liver), liver cancer and liver failure, the researchers said.
“Our study showed awareness of HCV infection among this particular population may motivate them to reduce their consumption and hopefully high-risk behavior,” said lead investigator Dr. Hooman Farhang Zangneh, a postdoctoral research fellow at the Toronto Centre for Liver Disease at Toronto General Hospital.
|Read Full Article: Hepatitis C Screening May Boost Opioid Treatment Success | Health Care | US News|